The NZD16.6M pathway to a NZ Stock Exchange Listing.
Seed Capital, "job done"
Series A-NZD6.6M NZ Production
Series A-NZD6.6M NZ Production
Between 2016 and 2023, USD387k (NZD650k) in seed capital was invested in developing the NZ-US cross-border ecosystem required to support the NZ "Seed-to-Ship" Natural Health Product ("NHP") supply system plus the "Ship-to-Shelf" distribution ecosystem.
Series A-NZD6.6M NZ Production
Series A-NZD6.6M NZ Production
Series A-NZD6.6M NZ Production
Our pathway to listing commences with the closing of the NZD6.6M Series A Round which enables (1) purchase of the factory land and buildings (2) extraction ops launch and shipment of first 20,000 kgs of oil to the Australian facility for value adding and shipping to the US for distribution.
Series B-NZD10M AU Ops
Series A-NZD6.6M NZ Production
Series B - US Operations
NZD6M of this has been allocated to the purchase of two GMP / TGA compliant Natural Health Product (NHP) manufacturing facilities in NSW, AU. One of the facilities is located on a 250 acre farm which includes a holiday villa style residence, factory worker lodging and acreage for cash cropping.
Series B - US Operations
Series B - US Operations
Series B - US Operations
NZD2.5M of the Series B has been allocated to purchase of a Related Affiliate Corp in the US that has operated an NHP distribution facility based in Valencia, CA. In operation for 14 years with an established NHP retail B2B customer base across the US.
NZX-IPO Listing?
Series B - US Operations
NZD239M Market Cap?
The successful closing of the Series A and B Rounds and their application to an investment into a profitable, going concern NHP operation in NZ, AU and the US, facilitates an application to list on the NZ Stock Exchange via IPO.
NZD239M Market Cap?
Series B - US Operations
NZD239M Market Cap?
The Company could undertake an IPO to raise acquisition capital, preceded by a 4:1 share split. A 20M share offer priced at NZD1 per share and assuming 112.8M shares on issue, trading at NZD2.12 per share end year 2 we have a NZD239M market cap company.
Yes. NZD16.6M can launch a NZD1B+ NZ tea tree sector.
In the "Triple K" triangle, one station alone has over NZD100M worth of unharvested NZ tea tree oil.
This therapeutic grade NZ tea tree oil will deliver.
NZ manuka & kanuka oil are efficacious as natural infection control remedies. Interestingly, kanuka oil wins in nosocomial infection protection.
With gender-specificity creating unique value adding.
And don't forget that circa 85% of the NZ tea tree resource is on customary tribal lands. So give the owners a fair go with resource extraction putea.
Your "Tribal" investment DD pathway starts here.
DOC-1880
DOC-1880
DOC-1880
There is no rocket science behind listing on the NZX. In just 7 pages, we illustrate the "7 Steps" to IPO and listing in one year. Doable!
DOC-1881
DOC-1880
DOC-1880
This 24 page brochure describes our NZD6.6M Series A and NZD10M Series B Rounds that will take us to listing.
DOC-1882
DOC-1880
DOC-1882
This is our 15 page "Pitch Deck". A slide show that pictorially illustrates our business pathway from seed to listing.
DOC-1883
DOC-1883
DOC-1882
Our 68 page, NZD6.6M Series A Round "Private Placement Memorandum" using the NASAA, Form U7 disclosure template.
DOC-1884
DOC-1883
DOC-1884
This is an abridged version of Form U7, issued to support the provisionally subscribed NZD10M Series B Round for the AU-US ops.
DOC-1888
DOC-1883
DOC-1884
An 8 page, Expression of Interest for Angel Investors to meet the Pre-Series A & B costs and provide an independent director.
Join the growing tide of Americans investing in NZ!
Enjoy "Endless Summer" investments in 3 countries.